Literature DB >> 10439826

New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review.

E C Lee1, S Walmsley, I G Fantus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10439826      PMCID： PMC1230467     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  24 in total

Review 1.  Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

Authors:  A Carr; K Samaras; D J Chisholm; D A Cooper
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

2.  Didanosine-induced disorders of glucose tolerance.

Authors:  H Albrecht; H J Stellbrink; K Arastéh
Journal:  Ann Intern Med       Date:  1993-11-15       Impact factor: 25.391

3.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

Authors:  J H Warram; B C Martin; A S Krolewski; J S Soeldner; C R Kahn
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

Review 4.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

Review 5.  Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.

Authors:  R A DeFronzo; E Ferrannini
Journal:  Diabetes Care       Date:  1991-03       Impact factor: 19.112

6.  Pathogenesis of NIDDM. A balanced overview.

Authors:  R A DeFronzo; R C Bonadonna; E Ferrannini
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

Review 7.  Drug-induced disorders of glucose tolerance.

Authors:  M K Pandit; J Burke; A B Gustafson; A Minocha; A N Peiris
Journal:  Ann Intern Med       Date:  1993-04-01       Impact factor: 25.391

8.  Diabetes mellitus following pentamidine-induced hypoglycemia in humans.

Authors:  P Bouchard; P Sai; G Reach; I Caubarrère; D Ganeval; R Assan
Journal:  Diabetes       Date:  1982-01       Impact factor: 9.461

Review 9.  Banting lecture 1990. Beta-cells in type II diabetes mellitus.

Authors:  D Porte
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

10.  Mechanism of FK506-induced glucose intolerance in rats.

Authors:  Y Hirano; T Mitamura; T Tamura; K Ohara; Y Mine; H Noguchi
Journal:  J Toxicol Sci       Date:  1994-05       Impact factor: 2.196
View more
  5 in total

1.  Protease inhibitor-induced diabetic complications : incidence, management and prevention.

Authors:  Lillian F Lien; Mark N Feinglos
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

3.  Direct interference of HIV protease inhibitors with pancreatic beta-cell function.

Authors:  M Düfer; Y Neye; P Krippeit-Drews; G Drews
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-07       Impact factor: 3.000

Review 4.  Adverse effects of antiretroviral therapy for HIV infection.

Authors:  Valentina Montessori; Natasha Press; Marianne Harris; Linda Akagi; Julio S G Montaner
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

5.  Reversible diabetes mellitus induced by use of, and improved after discontinuation of, the antiretroviral medication zidovudine: a case report.

Authors:  Kentaro Iwata; Wataru Ogawa
Journal:  J Med Case Rep       Date:  2017-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.